Premium
Injectable Supramolecular Hydrogel/Microgel Composites for Therapeutic Delivery
Author(s) -
Chen Minna H.,
Chung Jennifer J.,
Mealy Joshua E.,
Zaman Samir,
Li Elizabeth C.,
Arisi Maria F.,
Atluri Pavan,
Burdick Jason A.
Publication year - 2019
Publication title -
macromolecular bioscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.924
H-Index - 105
eISSN - 1616-5195
pISSN - 1616-5187
DOI - 10.1002/mabi.201800248
Subject(s) - self healing hydrogels , materials science , composite number , rheology , microfluidics , biomedical engineering , swelling , composite material , chemical engineering , polymer chemistry , nanotechnology , medicine , engineering
Shear‐thinning hydrogels are useful for biomedical applications, from 3D bioprinting to injectable biomaterials. Although they have the appropriate properties for injection, it may be advantageous to decouple injectability from the controlled release of encapsulated therapeutics. Toward this, composites of hydrogels and encapsulated microgels are introduced with microgels that are fabricated via microfluidics. The microgel cross‐linker controls degradation and entrapped molecule release, and the concentration of microgels alters composite hydrogel rheological properties. For the treatment of myocardial infarction (MI), interleukin‐10 (IL‐10) is encapsulated in microgels and released from composites. In a rat model of MI, composites with IL‐10 reduce macrophage density after 1 week and improve scar thickness, ejection fraction, cardiac output, and the size of vascular structures after 4 weeks when compared to saline injection. Improvements are also observed with the composite without IL‐10 over saline, emphasizing the role of injectable hydrogels alone on tissue repair.